FDA Drug Application (062646) for ULTRAGRIS-330 by PLIVA

Back to FDA Applications sponsored by PLIVA

Application Number062646
Product Number001
FormTABLET;ORAL
Dosage330MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameULTRAGRIS-330
Active IngredientGRISEOFULVIN, ULTRAMICROCRYSTALLINE

Active IngredientCount
List of drugs with Active Ingredient GRISEOFULVIN, ULTRAMICROCRYSTALLINE6


Back to FDA Applications sponsored by PLIVA